search icon

    Market Snapshot

    • S&P Futures


    • Dow Futures


    • Nasdaq Futures


    blog search icon

    Arrowhead Pharmaceuticals, Inc.





    Arrowhead Pharmaceuticals, Inc. Chart

    ARWR Stock Price Today

    Arrowhead Pharmaceuticals, Inc. (ARWR) stock rallied over 8.52% intraday to trade at $34.26 a share on NASDAQ. The stock opened with a gain of 14.97% at $31.75 and touched an intraday high of $34.3, rising 8.52% against the last close of $31.57. The stock went to a low of $31.68 during the session.

    Stock Snapshot


    Prev. Close

    3.46 Billion

    Market Cap


    Day Low



    105.55 Million

    Number of Shares


    Day High


    P/E ratio


    EPS (TTM)


    Cash Flow per Share


    Free Float in %


    Book Value



    Arrowhead Pharmaceuticals, Inc. Historical Data


    Contact Details

    177 East Colorado Boulevard
    Suite 700
    Pasadena, CA 91105
    United States


    626 304 3400

    Company Information



    Sales or Revenue144.42 Million

    5Y Sales Change287.50%

    Fiscal Year Ends2021-09-29

    SectorHealth Care


    About Company

    Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in Phase 2b clinical trial to reduce production of angiopoietin-like protein 3; ARO-HSD, which is in Phase 1/2a clinical trial to treat liver diseases; ARO-ENaC, which is in a Phase 1/2a clinical trial to reduce production of the epithelial sodium channel alpha subunit in the airways of the lung; ARO-C3 for the treatment of complement-mediated disease that is in Phase 1/2a clinical trial; ARO-Lung2 for the treatment of chronic obstructive pulmonary disorder; ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-XDH to treat uncontrolled gout; ARO-COV for the treatment of COVID-19 and other pulmonary-borne pathogens; and ARO-HIF2, which is in phase 1b clinical trial to treat clear cell renal cell carcinoma. It is also involved in the development of JNJ-3989, a subcutaneously administered RNAi therapeutic candidate to treat chronic hepatitis B virus infection; Olpasiran to reduce the production of apolipoprotein A; and ARO-AMG1 for treating genetically validated cardiovascular targets. Arrowhead Pharmaceuticals, Inc. has a license and research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop ARO-JNJ1, ARO-JNJ2, and ARO-JNJ3 RNAi therapeutics for liver-expressed targets; and license and research collaboration agreement with Takeda Pharmaceuticals U.S.A., Inc. to develop RNAi therapeutic candidate as a treatment for liver disease. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California.

    Frequently Asked Questions


    What is the current Arrowhead Pharmaceuticals, Inc. (ARWR) stock price?

    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) stock price is $34.26 as of the last check on Thursday, June 23. During the trading session, ARWR stock reached the peak price of $34.3 while $31.68 was the lowest point it dropped to.


    ARWR's industry and sector of operation?

    The NASDAQ listed ARWR is part of Biotechnology industry that operates in the broader Health Care sector. Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States.


    Who are the executives of ARWR?

    Dr. Vincent Anzalone
    VP of Investor Relations
    Dr. Christopher R. Anzalone Ph.D.
    CEO, Pres & Director
    Mr. Kenneth A. Myszkowski
    Chief Financial Officer
    Mr. Patrick O'Brien
    Chief Compliance Officer, Gen. Counsel & Corp. Sec.


    What is the ARWR stock price today?

    ARWR stock traded closed the last session at $34.26, which is $2.69 or 8.52% lower than its previous close of $31.57. ARWR's current trading price is 27.79% lower than its 52-week high of $93.66 where as its distance from 52-week low of 26.81% is -63.42%.


    How many employees does ARWR have?

    Number of ARWR employees currently stands at -. ARWR operates from 177 East Colorado Boulevard, Suite 700, Pasadena, CA 91105, United States.


    Link for ARWR official website?

    Official Webiste of $ARWR is:


    How do I contact ARWR?

    ARWR could be contacted at ARWR operates from 177 East Colorado Boulevard, Suite 700, Pasadena, CA 91105, United States, or at phone #626 304 3400 and can also be accessed through its website.


    How many shares of ARWR are traded daily?

    ARWR stock volume for the day was 907,755 shares while in the previous session number of ARWR shares traded was 909,700 . The average number of ARWR shares traded daily for last 3 months was 840.87 Thousands.


    How much did ARWR change today?

    The percentage change in ARWR stock occurred in the recent session was 8.52% while the dollar amount for the price change in ARWR stock was $2.69.


    What price range ARWR stock been trading in?

    In the recent session, the day high for ARWR stock was $34.3 while the low for ARWR stock touched on the day was $31.68.


    What is the market cap of ARWR currently?

    The market value of ARWR currently stands at 3.46 Billion with its latest stock price at $34.26 and 105.55 Million of its shares outstanding.